PAR-1 antagonists (Merck & Co)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamePAR-1 antagonists (Merck & Co)
Drug Alias Nameplatelet thrombin receptor antagonists (Merck & Co)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtease-activated receptor-1 antagonistsFactor IIa inhibitors
TargetsProtease-activated receptor-1Prothrombin
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A